Plasma prostaglandins in hypercalcemic patients with neoplastic disease
- 1 April 1977
- Vol. 39 (4), 1559-1562
- https://doi.org/10.1002/1097-0142(197704)39:4<1559::aid-cncr2820390430>3.0.co;2-3
Abstract
Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalcemic group had extensive metastases to bone. These findings support the recently developed hypothesis that prostaglandins are causally related to the genesis of hypercalcemia in malignancy.This publication has 12 references indexed in Scilit:
- Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of CancerNew England Journal of Medicine, 1975
- Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbitMetabolism, 1975
- Elevated Prostaglandins and Suppressed Parathyroid Hormone Associated with Hypercalcemia and Renal Cell CarcinomaJournal of Clinical Endocrinology & Metabolism, 1975
- BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASESThe Lancet, 1975
- Differential in vivo pulmonary degradation of prostaglandins E1, B1, and A1American Journal of Physiology-Legacy Content, 1975
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaNew England Journal of Medicine, 1974
- Prostaglandin F in monkey uterine fluid during the menstrual cycle and following steroid treatmentProstaglandins, 1974
- INDOMETHACIN IN BREAST CANCERThe Lancet, 1973
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972